Mitchell P. Kopin 13D/13G Filings for Pasithea Therapeutics Corp. (KTTA)

Mitchell P. Kopin 13D and 13G filings for Pasithea Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-12
4:08 pm
Purchase
2025-05-0613GPasithea Therapeutics Corp.
KTTA
Mitchell P. Kopin317,863
4.990%
317,863increase
(New Position)
Filing